Solesence financials
$0.8200−1.44%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 |
|---|---|
| Revenue | $62.1M |
| Gross profit | $16.1M |
| Gross margin | 25.9% |
| Operating income | $1.6M |
| Net income | $1.8M |
| Net margin | 2.9% |
| Diluted EPS | $0.02 |
| EBITDA | $2.5M |
| Operating cash flow | -$8.6M |
| Free cash flow | -$10.7M |
| Diluted shares | 72.6M |
Balance sheet
| Period end | Dec 31 |
|---|---|
| Cash & equivalents | $1.3M |
| Short-term investments | $0.00 |
| Total debt | $15.3M |
| Total assets | $46.5M |
| Total liabilities | $32.4M |
| Shareholders' equity | $14.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology